Your doctor measures your weight. Your BMI. Your cholesterol. Your blood pressure. These are the standard metrics of the annual physical, the benchmarks that define whether you are healthy or at risk.

None of them measure the one thing that research increasingly identifies as among the strongest independent predictors of how long you will live and how well you will function as you age.

Muscle mass.

The evidence on muscle mass and longevity is not subtle, and it is not new. But it remains almost entirely absent from the conversation your doctor has with you about how to protect your healthspan. The reason is not that doctors do not know. It is that the intervention, resistance training, does not come in a bottle, does not require a prescription, and cannot be sold at a margin.

The dose required to capture most of the mortality benefit is lower than almost anyone realizes.

Let’s run it through the filter.

Muscle is not just tissue that moves your body. It is a metabolically active organ that regulates glucose disposal, produces anti-inflammatory myokines, supports bone density, protects joints, and maintains the functional capacity that determines whether you can live independently as you age.

A landmark study of 3,659 adults from the National Health and Nutrition Examination Survey followed participants for 10 to 16 years. Adults in the highest quartile of muscle mass index had a 20% lower all-cause mortality risk compared to those in the lowest quartile, independently of fat mass, cardiovascular risk factors, and metabolic markers including blood pressure, cholesterol, and insulin resistance.

That last part matters. Muscle mass is not simply a proxy for being generally healthy. It is an independent predictor of survival. The mechanism is direct: skeletal muscle regulates glucose metabolism, produces hormones that protect cardiovascular and cognitive function, and provides the physical reserve that prevents the cascade of decline that begins with a fall, a fracture, or a hospital admission.

After age 30, you begin losing muscle mass. After 50, the decline accelerates. The medical term is sarcopenia. By your 70s, it affects 10 to 22% of all adults and is directly associated with falls, fractures, loss of independence, and accelerated mortality. It is the default trajectory for anyone who does not actively intervene.

Resistance training is the intervention.

Yes. The evidence base is among the strongest in all of exercise science.

ALL-CAUSE MORTALITY: Strong, consistent evidence. A systematic review and meta-analysis published in the British Journal of Sports Medicine found resistance training associated with a 10–20% reduction in all-cause mortality risk, cardiovascular disease mortality, and cancer-specific mortality. This is among the strongest mortality reduction signals of any single intervention, supplement, medication, or behavior, studied in this demographic.

CARDIOVASCULAR HEALTH: Confirmed by the American Heart Association. A 2024 AHA scientific statement confirmed resistance training improves blood pressure, blood lipids, blood sugar, and body composition. The statement also confirmed that approximately 30–60 minutes per week of resistance training is associated with maximum risk reduction for all-cause mortality and incident cardiovascular disease. This is the most authoritative dose-response statement in the field.

MUSCLE MASS AND SARCOPENIA: Overwhelming evidence. Resistance training is the only intervention with consistent, replicated evidence for preserving and building skeletal muscle mass in older adults. A 2025 systematic review of 24 RCTs in older adults with sarcopenia confirmed significant improvements in handgrip strength, gait speed, knee extension strength, and functional capacity vs no intervention. The 2025 ACSM guidelines confirm that any form of resistance exercise, including bodyweight and elastic bands, improves strength, muscle size, power, and physical function.

METABOLIC HEALTH: Consistent evidence. Resistance training improves insulin sensitivity, reduces visceral fat, and lowers HbA1c. For the 40–70 demographic, where insulin resistance is a primary driver of cardiovascular disease and type 2 diabetes risk, this is a clinically meaningful secondary benefit that stacks on top of the mortality signal.

COGNITIVE FUNCTION: Accumulating evidence. Multiple RCTs have found resistance training associated with improvements in executive function, memory, and processing speed in older adults. The mechanism is partly cardiovascular (improved cerebral blood flow), partly hormonal (increased BDNF and IGF-1), and partly metabolic (improved glucose regulation). Not as strong as the muscle and cardiovascular evidence, but directionally consistent.

The mortality data is primarily observational, it shows association, not causation in the strictest sense. People who do resistance training may differ systematically from those who do not in ways the studies cannot fully control for. However, the biological mechanisms are well-established, the dose-response relationship is consistent, and the effect sizes are large enough that the evidence is treated as causal by the major clinical bodies including the AHA and ACSM.

The optimal dose for maximum muscle hypertrophy is higher than the minimum effective dose for mortality benefit, roughly 10 sets per muscle group per week for maximum size, vs 2–3 sets twice a week for the majority of the health and mortality benefit. This edition focuses on the minimum effective dose for healthspan, not bodybuilding.

Bodyweight training is confirmed effective for strength and function, but progressive overload, gradually increasing difficulty, is important for continued adaptation. Bodyweight training that never gets harder stops producing the same stimulus.

This question runs differently for a behavioral intervention with no financial cost.

The question is whether 30–60 minutes per week is worth a 10–20% reduction in all-cause mortality risk, preserved muscle mass, improved cardiovascular markers, better metabolic health, and maintained functional independence as you age.

For context: the most commonly prescribed statin drugs reduce cardiovascular mortality risk by approximately 25–35% in high-risk populations. Resistance training, at 30–60 minutes per week, produces mortality risk reductions in the same order of magnitude, at zero cost, with no side effects, and with additional benefits that statins do not provide.

The ROI is unmatched by almost any intervention in the healthspan space.

This recommendation is for otherwise healthy adults. Two notes:

There is no supplement in the sports nutrition aisle with a 10–20% all-cause mortality reduction signal. There is no wellness device with that evidence base. There is no longevity protocol with that consistency across populations and time horizons.

Resistance training has all of it. It has had it for decades. It is free, requires no equipment at the minimum effective dose, and can be started this week by anyone reading this.

The reason only 28% of US adults meet resistance training guidelines is not access, cost, or complexity. It is that nobody has clearly communicated what the minimum dose is and why it matters. The guidelines say “two or more days per week” with no duration specified. That ambiguity is a barrier. The evidence is clear on duration: 30 to 60 minutes per week total.

That is two sessions of 15 to 30 minutes.

The system has been overcomplicating this for decades. The MED Report is here to stop that.

FREQUENCY: 2 sessions per week. Non-consecutive days (e.g. Monday and Thursday).

DURATION: 20–30 minutes per session. 30–60 minutes total per week.

STRUCTURE: 2–3 sets per exercise. 8–15 repetitions per set. All major muscle groups.

INTENSITY: Challenging but not to failure. The last 2–3 reps should feel difficult.

EQUIPMENT: None required. Bodyweight is sufficient to start.

This covers all major muscle groups in under 30 minutes, twice a week. No equipment. No gym.

Progressive overload principle: when 3 sets of 15 reps feels easy, add difficulty. Slower tempo, pause at the bottom, or add a resistance band or weight. The stimulus must continue to challenge the muscle.

If you read Edition #003, you already know that creatine monohydrate (3–5g/day) combined with resistance training produces approximately 3 lbs. more lean mass than resistance training alone. The two interventions compound each other. This is the most evidence-based supplement stack in the 40–70 demographic: resistance training twice a week plus 3–5g creatine monohydrate daily.

Subscribe free — one edition in your inbox every Wednesday. No spam. No conflicts of interest. Any future sponsorships will be clearly disclosed and personally vetted.

After subscribing, check your junk/spam folder for the confirmation email and mark it as ‘Not Spam’ to ensure delivery.